Dilemma of the natural history of hepatitis C

Journal of Gastroenterology and Hepatology (Australia)

Volumn 14, Issue 3, 1999, Pages 199-201

  Seeff, L B ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE;

BLOOD TRANSFUSION; CHRONIC HEPATITIS; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE MARKER; EDITORIAL; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; LABORATORY DIAGNOSIS; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; MORTALITY; PATIENT SELECTION; PRIORITY JOURNAL; SERODIAGNOSIS; TERMINAL DISEASE; VIRUS LOAD;

EID: 0032941144     PISSN: 08159319     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1440-1746.1999.01837.x     Document Type: Editorial

References (28)

1. 1 Rodger AJ, Thomson JA, Thompson SC et al. Assessment of long‐term outcomes of hepatitis C virus infection in a cohort of patients with acute hepatitis in 1971–1975: Results of a pilot study. J. Gastroenterol. Hepatol. 1999 ; 14: 269–73.
2. 2 Feinstone SM, Kapikian AZ, Purcell RH et al. Transfusion‐associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 1975 ; 292: 767–70.
3. 3 Aach RD, Szmuness W, Mosley JW et al. Serum alanine aminotransferase of donors in relation to risk of non‐A, non‐B hepatitis in recipients: The transfusion‐transmitted viruses study. N. Engl. J. Med. 1981 ; 304: 989–94.
4. 4 Alter HJ, Purcell RH, Feinstone SM et al. Non‐A/non‐B hepatitis: A review and interim report of an ongoing prospective study. In: Vyas GN, Cohen SM, Schmidt R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press, 1978; 359–81.
5. 5 Seeff LB, Wright EC, Zimmerman HJ et al. A randomized, double‐blind, controlled trial of the efficacy of immune serum globulin for the prevention of post‐transfusion hepatitis. Gastroenterology 1977 ; 72: 111–21.
6. 6 Seeff LB, Wright EC, Zimmerman HJ et al. Post‐transfusion hepatitis 1973–1975: A veterans administration cooperative study. In: Vyas GN, Cohen SM, Schmidt R, eds. Viral Hepatitis. Philadelphia: Franklin Institute Press, 1978; 219–42.
7. 7 Knodell RG, Conrad ME, Ginsberg AL et al. Efficacy of prophylactic gamma‐globulin in preventing non‐A, non‐B post‐transfusion hepatitis. Lancet 1976 ; ii: 557–61.
8. 8 Choo Q‐L, Kuo G, Weiner AJ et al. Isolation of a cDNA clone derived from a blood‐borne non‐A, non‐B hepatitis genome. Science 1989 ; 244: 359–62.
9. 9 Kuo G, Choo Q‐L, Alter HJ et al. An assay for circulating antibodies to a major etiologic virus of human non‐A, non‐B hepatitis. Science 1989 ; 244: 362–4.
10. 10 Dienstag JL. Non‐A, non‐B hepatitis. I. Recognition, epidemiology and clinical features. Gastroenterology 1983 ; 85: 439–62.
11. 11 Gilliam JH, Geisinger K, Richter JE. Primary hepatocellular carcinoma after non‐A, non‐B post‐transfusion hepatitis. Ann. Intern. Med. 1984 ; 101: 794–5.
12. 12 Kiyosawa K, Akahane Y, Nogata A, Furuta S. Hepatocellular carcinoma after non‐A, non‐B post‐transfusion hepatitis. Am. J. Gastroenterol. 1984 ; 79: 777–81.
13. 13 Bruix J, Calvet X, Costa J et al. Prevalence of antibodies to hepatitis C virus in Spanish patients with hepatocellular carcinoma and hepatic cirrhosis. Lancet 1989 ; ii: 1004–6.
14. 14 Colombo M, Kuo G, Choo QL et al. Prevalence of antibodies to hepatitis C virus in Italian patients with hepatocellular carcinoma. Lancet 1989 ; ii: 1006–8.
15. 15 Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship of blood transfusion, non‐A, non‐B hepatocellular carcinoma: Analysis by detection of antibody to hepatitis C virus. Hepatology 1990 ; 12: 671–5.
16. 16 Alter HJ, Conry‐Cantilena C, Melpolder J et al. Hepatitis C in asymptomatic blood donors. Hepatology 1997 ; 26 3: S29–33.
17. 17 Alter MJ, Margolis HS, Krawczynski K et al. The natural history of community‐acquired hepatitis C in the United States. N. Engl. J. Med. 1992 ; 327: 899–905.
18. 18 Tong MJ, El‐Farra NS, Raikes AR, Co RL. Clinical outcomes after transfusion‐associated hepatitis C. N. Engl. J. Med. 1995 ; 332: 1463–6.
19. 19 Takahashi M, Yamada G, Miyamoto R et al. Natural history of chronic hepatitis C. Am. J. Gastroenterol. 1993 ; 88: 240–3.
20. 20 Pessoa MG & Wright TC. Hepatitis C infection in transplantation. Clin. Liver Dis. 1997 ; 1: 663–90.
21. 21 Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Semin. Liver Dis. 1995 ; 15: 64–9.
22. 22 Di Bisceglie AM. Hepatitis C and hepatocellular carcinoma. Hepatology 1997 ; 26 3: 345–85.
23. 23 Seeff LB, Buskell‐Bales Z, Wright EC et al. Long‐term mortality of transfusion‐associated non‐A, non‐B hepatitis. N. Engl. J. Med. 1992 ; 327: 1906–11.
24. 24 Seeff LB, Hollinger FB, Alter HJ et al. Long‐term morbidity of transfusion‐associated hepatitis (TAH). Hepatology 1998 ; 4: 407 A (Abstract).
25. 25 Crowe J, Doyle C, Fielding JF et al. Presentation of hepatitis C in a uniform cohort 17 years from inoculation. Gastroenterology 1995 ; 108: A1054.
26. 26 Roudet‐Thoraval, Bastie A & Pawloski K et al. Epidemiological factors affecting the severity of hepatitis C virus‐related liver disease: A French survey of 6664 patients. Hepatology 1997 ; 26: 491–4.
27. 27 Gordon SC, Bayati N, Silverman AL. Clinical outcome of hepatitis C as a function of mode of transmission. Hepatology 1998 ; 28: 562–7.
28. 28 Poynard T, Bedossa P, Opolon P. Natural history of liver fibrosis progression in patients with chronic hepatitis C. Lancet 1997 ; 349: 825–32.